Not Yet RecruitingNot Applicable

Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income

72 participantsStarted 2026-03-20

Plain-language summary

The goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participants in Kansas who are \<13 weeks gestation, age ≥18, and moderate or high risk for preeclampsia (USPSTF). The main question\[s\] it aims to answer \[is/are\]: Does Centering HER increase hypertension monitoring and aspirin compliance compared with usual doula care? Is Centering HER feasible and acceptable, and what contextual factors influence implementation in community clinics?

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * English or Spanish speaking * \<13 weeks gestations * \>18 years old * moderate or high risk for hypertensive disorders in pregnancy Exclusion Criteria: * less than18 years of age * not receiving prenatal care * not eligible for doula care * no risk factors for hypertensive disorders in pregnancy

What they're measuring

Blood Pressure

Timeframe: Week 1- Week 12; delivery, and 3 and 6 months postpartum

Trial details

NCT IDNCT07491510

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-30

View on ClinicalTrials.gov More High Blood Pressure (& [Essential Hypertension]) trials